X4 Pharmaceuticals (XFOR)
(Delayed Data from NSDQ)
$1.15 USD
+0.07 (6.48%)
Updated May 3, 2024 04:00 PM ET
After-Market: $1.15 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: BMO |
3/2024 | $-0.17 | 15.15% |
Earnings Summary
For their last quarter, X4 Pharmaceuticals (XFOR) reported earnings of -$0.10 per share, beating the Zacks Consensus Estimate of $-0.15 per share. This reflects a positive earnings surprise of 33.33%. Look out for XFOR's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year decrease of 6.25%.
Earnings History
Price & Consensus
Zacks News for XFOR
All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy
XFOR: What are Zacks experts saying now?
Zacks Private Portfolio Services